期刊文献+

泌尿系感染患者中段尿液中肠球菌属的耐药性分析 被引量:8

Drug resistance of enterococcus in middle-segment urine of patients with in urinary tract infection
原文传递
导出
摘要 目的了解泌尿系感染患者中段尿液中肠球菌属的分布及其耐药情况。方法收集2019例泌尿系感染患者中段尿液进行细菌培养、鉴定及药敏试验。结果 454例中检出细菌493株,阳性率为22.49%,其中肠球菌属151株,分离率为30.63%,大肠埃希菌137株,分离率为27.79%;粪肠球菌对青霉素及呋喃妥因、喹诺酮类抗菌药物的耐药率明显低于屎肠球菌,屎肠球菌对喹奴普汀/达福普汀的耐药率明显低于粪肠球菌;粪肠球菌及屎肠球菌未见对万古霉素和替考拉宁耐药。结论肠球菌属在尿液中细菌检出率较高,对常见抗菌药物均存在不同程度的耐药性,对万古霉素和替考拉宁具有高度的敏感性,药敏试验结果可指导临床合理选用抗菌药物。 OBJECTIVE To analyze the resistance feature and the distribution of Enterococcus species isolated from middle-segment urine specimens.METHODS Totally 732 samples of middle-segment urine of patients infected in urinary tract were cultured,and the drug resistances were tested.RESULTS From them 493 strains in 454 cases were detected out,among which 151 strains were Enterococcus and 137 strains were Escherichia coli.The results of drug resistances showed the resistant rates of E.faecalis to penicillin and furadantin were lower than those of E.faecium,the resistant rate of E.faecium to quinupristin/dalfopristin was lower than that of E.faecalis.None of E.faecalis and E.faecium resisted to vancomycin and teicoplanin.CONCLUSION The detective rate of the Enterococcus is high in middle-segment urine specimens.The results reveal a different resistance to common antibiotics,but a high sensistivity to vancomycin and teicoplanin.The result of antibiotic susceptibility testing guides the rational use of antibacterial agents.
作者 丁洁卫
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第8期1697-1698,共2页 Chinese Journal of Nosocomiology
关键词 中段尿 肠球菌属 抗菌药物 耐药性 Middle-segment urine Enterococcus Antibacterial drug Drug resistance
  • 相关文献

参考文献5

  • 1Mohanty S, Jose S, Singhal R, et al. Species prevalence and antimicrobial susceptibility of enteroeocci isolated in a tertiary care hospital of North India[J]. Southeast Asian J Trop Med Public Health, 2005,36 (4) : 962-965.
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimierobial susceptibility testing [S]. Ninth informational supplement, M100-S9. NCCLS, 1999: 27-75.
  • 3林奇龙,夏邦世,沈忠海,朱素娟,陈芬.201株肠球菌属的临床分布及耐药分析[J].中华医院感染学杂志,2009,19(7):858-860. 被引量:32
  • 4胡志东 王金良.肠球菌耐药性的研究进展.国际流行病学传染病学杂志,2007,34(4):284-284.
  • 5于艳华,许淑珍.37株耐万古霉素屎肠球菌基因型及同源性分析[J].中华医院感染学杂志,2007,17(8):917-919. 被引量:33

二级参考文献12

共引文献75

同被引文献54

  • 1唐晓丹,李光辉,吴菊芳.肠球菌感染研究现状[J].中国感染与化疗杂志,2007,7(3):221-224. 被引量:39
  • 2Yengkokpam C, lngudam D, Yengkokpam IS, et al. Antibiotic susceptibility pattern of urinary isolates in Imphal(Manipur), India[J]. Nepal Med Coil J,2007,9(3) :170-172.
  • 3叶应妩,王毓久,申子瑜,等.全国临床检验操作规程[S].3版.北京:中华人民共和国卫生部,2006.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteeth informational supplement[M]. Wayne: Clinical and Laboratory Standards Institute, 2009.
  • 5朱建国,周贵民.临床微生物检验[M]//中华人民共和国卫生部医政司.全国临床检验操作规程.3版.南京:东南大学出版社,2006:715-926.
  • 6叶应抚,王毓三,申子瑜.全国临床检验操作规程(第3版)[M].南京:东南大学出版社,2006:736-753.
  • 7Clinical and Laboratory Standards Institute.Performance standards for antimicrobials susceptibility testing; twenty-first informational supplement[S].M100-S21,CLSI,2011:82-84.
  • 8Murray BE,Mederski-Samaroj B.Transferable beta-lactamase.A new mechanism for in vitro penicillin resistance in Streptococcus faecalis[J].J Clin Invest,1983,72:1168-1171.
  • 9Magiorakos AP,Srinivasan A,Carey RB,et al.Multidrug-resist-ant,extensively drug-resistant and pandrug-resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance[J].Clin Microbiol Infect,2012,18:268-281.
  • 10Sarti M,Campanile F,Sabia C,et al.Polyclonal diffusion of beta-lactamase-producing Enterococcus faecium[J].J Clin Microbiol,2012,50:169-172.

引证文献8

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部